Clinical study on the efficacy and tolerability of mesalazine granules vs. placebo for the prevention of recurrence of diverticulitis

Registry ID

EUCTR2009-015158-39

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE3

Sponsor

Dr. Falk Pharma GmbH

Start date

2010-03-31

Last update

2026-08-16

Conditions

• Diverticulitis

Summary

-To compare the efficacy and tolerability of two doses mesalazine granules (1.5 g and 3 g 5-ASA/d) vs. placebo for the prevention of recurrence of diverticulitis

Locations

• , , Spain
• , , Greece
• , , Finland
• , , Sweden
• , , Germany
• , , Belgium

Related clinical trials

• Anastomotic Leakage After Colorectal Surgery.
• Diagnosis of Abdominal Pain Using RNA Levels: The NATURAL Study
• Anastomotic Bleeding in Colorectal Anastomosis Relating to the Placement of the Stapler Spike to the Staple Line
• Clinical Trial With MBK-01, Intestinal Microbiota Capsules, for the Treatment of Patients With Recurrent Diverticulitis
• Surgical Site Infection Outcomes in Natural Orifice Intracorporeal Anastomosis and Extraction (NICE) Procedure - The NICE Trial
• Comparison of NOM for ACLD Between Medical and Surgical Ward

View on source registry